SCOPUS 정보 검색 플랫폼

Clinical Pharmacokinetics

Volumn 41, Issue 3, 2002, Pages 161-169

The product label: How pharmacokinetics and pharmacodynamics reach the prescriber

(2) Marroum, Patrick J a Gobburu, Jogarao a

a CENTER FOR DRUG EVALUATION AND RESEARCH (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; CYTOCHROME P450 3A4; DEXAMETHASONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROMYCIN; ITRACONAZOLE; KETOCONAZOLE; PHENOBARBITAL; PHENYTOIN; RIFAMPICIN; SILDENAFIL; THIAZIDE DIURETIC AGENT;

AREA UNDER THE CURVE; CLINICAL TRIAL; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG COMPETITION; DRUG DISPOSITION; DRUG INDUSTRY; DRUG INFORMATION; DRUG LABELING; DRUG LEGISLATION; FOOD AND DRUG ADMINISTRATION; FOOD DRUG INTERACTION; GRAPEFRUIT JUICE; HUMAN; KIDNEY FAILURE; LIVER FAILURE; PHARMACODYNAMICS; PHYSICIAN; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; REVIEW;

DRUG APPROVAL; DRUG INDUSTRY; DRUG INTERACTIONS; DRUG LABELING; HUMANS; PHARMACOKINETICS; PHARMACOLOGY, CLINICAL; PHYSICIAN'S ROLE; PRESCRIPTIONS, DRUG; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0036224186 PISSN: 03125963 EISSN: None Source Type: Journal
DOI: 10.2165/00003088-200241030-00001 Document Type: Review

Times cited : (23)

References (19)

1
- 0026504422
- Opportunities for integration of pharmacokinetics, pharmacodynamics and toxicokinetics in rational drug development
- Apr
- (1992) Clin Pharmacol Ther , vol.51 , Issue.4 , pp. 465-473
- Peck, C.C.¹ Barr, W.H.² Benet, L.Z.³

2
- 85021438184
- General requirements on content and format of labeling for human prescription drugs, Code of Federal Regulations, 21 Part 201.56. Revised as of 1 April 2000. Washington, DC: US Government Printing Office, 2000

3
- 85021451795
- Specific requirements on content and format of labeling for human prescription drugs, Code of Federal Regulations, 21 Part 201.57. Revised as of 1 April 2000. Washington, DC: US Government Printing Office, 2000

4
- 14044267086
- Rockville (MD): US Department of Health and Human Services, Public Health Service, Food and Drug Administration, May
- (1998) Providing clinical evidence of effectiveness for human drug and biological drugs

5
- 0346128425
- Rockville (MD): US Department of Health and Human Services, Public Health Service, Food and Drug Administration, Nov
- (1998) General considerations for pediatric pharmacokinetic studies for drugs and biological products

6
- 85021406315
- Specific requirements on content and format of labeling for human prescription drugs, Code of Federal Regulations. 21 Part 201.57 (f)(10). Revised as of 1 April 2000. Washington, DC: US Government Printing Office

7
- 4243892412
- Groton (CT): Pfizer
- (2001) Viagra® (sildenafil citrate) [package insert]

8
- 0003556717
- Rockville (MD): US Department of Health and Human Services, Public Health Service, Food and Drug Administration, May
- (1998) Pharmacokinetics in patients with renal function - study design, data analysis, and impact on dosing and labeling

9
- 9644287201
- Rockville (MD): US Department of Health and Human Services, Public Health Service, Food and Drug Administration, Nov
- (1999) Pharmacokinetics in patients with impaired hepatic function: study design, data analysis, and impact on dosing and labeling

10
- 0003701608
- Rockville (MD): US Department of Health and Human Services, Public Health Service, Food and Drug Administration, Apr
- (1997) Drug metabolism/drug interaction studies in the drug development process: studies in vitro

11
- 0004228314
- Rockville (MD): US Department of Health and Human Services, Public Health Service, Food and Drug Administration, Nov
- (1999) In vivo drug metabolism/drug interaction studies-study design, data analysis, and recommendations for dosing and labeling

12
- 0032778908
- In vitro metabolic interaction studies: Experience of the Food and Drug Administration
- (1999) Clin Pharmacol Ther , vol.66 , pp. 9-15
- Yuan, R.¹ Parmelee, T.² Balian, J.³

13
- 0003838826
- Rockville (MD): US Department of Health and Human Services, Public Health Service, Food and Drug Administration, Feb
- (1999) Population pharmacokinetics

14
- 0004044177
- Rockville (MD): US Department of Health and Human Services, Public Health Service, Food and Drug Administration, Oct
- (1997) Food effect bioavailability and bioequivalence studies

15
- 0008847561
- Requirements on content and format of labeling for human prescription drugs and biologics, requirements for prescription drug products labels, proposed rule
- Dec 22
- (2000) Fed Regist , vol.65 , pp. 247

16
- 0008870012
- Contract No. 223-91-3501, Feb
- (1992) Focus Group Report. Physician's perceptions of prescription drug labeling information

17
- 0034077111
- Assessment and reporting of clinical pharmacology information in drug labeling
- Mar
- (2000) Clin Pharmacol Ther , vol.67 , Issue.3 , pp. 196-200
- Spyker, D.¹ Harvey, E.² Harvey, B.³

18
- 4243381356
- Princeton (NJ): Bristol Myers Squibb
- (2001) Avapro® (irbesartan) [package insert]

19
- 25744454691
- Westborough (MA): AstraZeneca
- (2001) Toprol XL® (metoprolol succinate extended-release tablets) [package insert]

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.